TOKYO, May 22 (Pulse News Wire) – Adr120s,inc. (3750.T) announced today that its board of directors has decided to propose amendments to the company's articles of incorporation at the upcoming 22nd Annual General Meeting scheduled for June 26, 2026.
The changes aim to reflect the company’s recent reorganization and future strategic direction. The proposed amendments include changing the company name from “ADR120S Corporation” to “ADR Biomedical Holdings Corporation,” along with updating the purpose of operations. The revised purposes will focus on regenerative medicine research, development, manufacturing, sales, medical device production, healthcare IT services, and investments in global healthcare-related businesses.
Under the amended articles, the effective date for the name change is set for July 1, 2026. The company expects the changes to align with previously disclosed plans related to restructuring activities and future business expansion. The annual general meeting will convene on June 26, 2026, to finalize the proposed amendments.
🟢 Confidence: High AI-translated content.